Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Legionnaires' Disease | 1 | 2024 | 49 | 0.950 |
Why?
|
Viruses | 3 | 2024 | 376 | 0.880 |
Why?
|
Rhabdomyolysis | 1 | 2024 | 155 | 0.860 |
Why?
|
Confusion | 1 | 2024 | 279 | 0.810 |
Why?
|
Drug Labeling | 1 | 2024 | 251 | 0.770 |
Why?
|
Influenza, Human | 3 | 2024 | 1528 | 0.730 |
Why?
|
Arbovirus Infections | 1 | 2020 | 21 | 0.730 |
Why?
|
Community-Acquired Infections | 1 | 2024 | 461 | 0.720 |
Why?
|
West Nile Fever | 1 | 2020 | 74 | 0.710 |
Why?
|
West Nile virus | 1 | 2020 | 76 | 0.710 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 1949 | 0.710 |
Why?
|
Metagenome | 2 | 2021 | 450 | 0.660 |
Why?
|
Anti-Bacterial Agents | 8 | 2024 | 7408 | 0.640 |
Why?
|
Central Nervous System Infections | 1 | 2019 | 61 | 0.640 |
Why?
|
Renal Insufficiency | 1 | 2024 | 820 | 0.620 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.610 |
Why?
|
Urinary Tract Infections | 2 | 2022 | 814 | 0.590 |
Why?
|
Enterococcus faecium | 1 | 2018 | 101 | 0.590 |
Why?
|
Drug Resistance, Bacterial | 3 | 2022 | 1055 | 0.580 |
Why?
|
Molecular Epidemiology | 1 | 2017 | 469 | 0.510 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 448 | 0.510 |
Why?
|
Pandemics | 10 | 2023 | 8624 | 0.500 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 981 | 0.450 |
Why?
|
Metagenomics | 3 | 2023 | 457 | 0.430 |
Why?
|
Influenza Vaccines | 1 | 2020 | 766 | 0.430 |
Why?
|
Bacteremia | 1 | 2018 | 980 | 0.380 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3085 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3205 | 0.360 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1462 | 0.330 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1407 | 0.310 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 749 | 0.270 |
Why?
|
Systems Biology | 1 | 2010 | 482 | 0.270 |
Why?
|
Respiratory Syncytial Viruses | 2 | 2024 | 167 | 0.250 |
Why?
|
Legionella pneumophila | 1 | 2024 | 49 | 0.240 |
Why?
|
Genome, Bacterial | 2 | 2021 | 770 | 0.230 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2010 | 1130 | 0.230 |
Why?
|
Metapneumovirus | 1 | 2024 | 28 | 0.230 |
Why?
|
Vibrio cholerae | 1 | 2010 | 793 | 0.230 |
Why?
|
Paramyxoviridae Infections | 1 | 2024 | 57 | 0.230 |
Why?
|
Disease Outbreaks | 2 | 2023 | 1758 | 0.200 |
Why?
|
Cryptococcus neoformans | 1 | 2022 | 121 | 0.200 |
Why?
|
Cryptococcosis | 1 | 2022 | 104 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 144 | 0.190 |
Why?
|
Serologic Tests | 2 | 2020 | 383 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.190 |
Why?
|
Seasons | 3 | 2023 | 1522 | 0.190 |
Why?
|
Carbapenems | 1 | 2022 | 123 | 0.190 |
Why?
|
Tuberculosis, Lymph Node | 1 | 2020 | 21 | 0.180 |
Why?
|
Shigella | 1 | 2021 | 69 | 0.180 |
Why?
|
Humans | 43 | 2024 | 760621 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3616 | 0.170 |
Why?
|
Lymphadenitis | 1 | 2020 | 98 | 0.170 |
Why?
|
Meningitis | 1 | 2021 | 218 | 0.170 |
Why?
|
Gentian Violet | 1 | 2019 | 29 | 0.170 |
Why?
|
Phenazines | 1 | 2019 | 56 | 0.170 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12965 | 0.160 |
Why?
|
Immune Evasion | 1 | 2022 | 362 | 0.150 |
Why?
|
Acyclovir | 1 | 2019 | 268 | 0.150 |
Why?
|
Sepsis | 2 | 2023 | 2592 | 0.150 |
Why?
|
Herpesvirus 3, Human | 1 | 2019 | 158 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 364 | 0.150 |
Why?
|
Income | 1 | 2006 | 1875 | 0.150 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2019 | 664 | 0.150 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 37 | 0.150 |
Why?
|
Virus Diseases | 1 | 2024 | 720 | 0.150 |
Why?
|
Encephalitis | 1 | 2021 | 437 | 0.150 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 43 | 0.150 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 856 | 0.150 |
Why?
|
Bacterial Proteins | 1 | 2010 | 3826 | 0.140 |
Why?
|
Propensity Score | 1 | 2024 | 1928 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2019 | 251 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3143 | 0.140 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2021 | 586 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1007 | 0.130 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1006 | 0.130 |
Why?
|
Vancomycin | 1 | 2018 | 503 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1933 | 0.120 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 445 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 857 | 0.120 |
Why?
|
Viral Load | 2 | 2021 | 3322 | 0.120 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4713 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1520 | 0.120 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9411 | 0.120 |
Why?
|
Physician's Role | 1 | 2020 | 918 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 786 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1374 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1607 | 0.100 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 694 | 0.090 |
Why?
|
Elephantiasis, Filarial | 2 | 2007 | 31 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2024 | 5425 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2159 | 0.090 |
Why?
|
Adult | 13 | 2024 | 219994 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6068 | 0.090 |
Why?
|
Diethylcarbamazine | 2 | 2007 | 23 | 0.090 |
Why?
|
Middle Aged | 14 | 2024 | 220352 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1903 | 0.080 |
Why?
|
Albendazole | 2 | 2007 | 50 | 0.080 |
Why?
|
Bacteriological Techniques | 1 | 2010 | 279 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2020 | 3486 | 0.080 |
Why?
|
United States | 7 | 2023 | 72461 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7064 | 0.080 |
Why?
|
Male | 15 | 2024 | 359744 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 21392 | 0.080 |
Why?
|
Culture Media | 1 | 2010 | 900 | 0.080 |
Why?
|
Cholera Toxin | 1 | 2010 | 559 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2024 | 80372 | 0.070 |
Why?
|
Anthelmintics | 1 | 2007 | 82 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3061 | 0.070 |
Why?
|
Virulence | 1 | 2010 | 1298 | 0.070 |
Why?
|
Plasmids | 2 | 2022 | 2275 | 0.070 |
Why?
|
Female | 13 | 2024 | 391270 | 0.070 |
Why?
|
Filaricides | 1 | 2005 | 10 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 12427 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20509 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2010 | 2698 | 0.050 |
Why?
|
Rhinovirus | 1 | 2024 | 202 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3775 | 0.050 |
Why?
|
Health Services | 1 | 2007 | 753 | 0.050 |
Why?
|
Candida | 1 | 2022 | 173 | 0.050 |
Why?
|
Eye Diseases | 1 | 2007 | 651 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15840 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 386 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 206 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2022 | 508 | 0.050 |
Why?
|
Aged | 8 | 2024 | 169152 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5649 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15757 | 0.050 |
Why?
|
Program Evaluation | 2 | 2007 | 2493 | 0.050 |
Why?
|
Health Resources | 1 | 2007 | 935 | 0.050 |
Why?
|
Groin | 1 | 2020 | 107 | 0.040 |
Why?
|
Dysentery, Bacillary | 1 | 2021 | 74 | 0.040 |
Why?
|
Purpura | 1 | 2020 | 116 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13981 | 0.040 |
Why?
|
Cross Reactions | 1 | 2022 | 818 | 0.040 |
Why?
|
Adenoviridae | 1 | 2024 | 1084 | 0.040 |
Why?
|
Hypercholesterolemia | 1 | 2006 | 1155 | 0.040 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2020 | 231 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 617 | 0.040 |
Why?
|
Educational Status | 1 | 2006 | 2515 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2007 | 1399 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 394 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 407 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2019 | 302 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25942 | 0.040 |
Why?
|
Diabetic Retinopathy | 1 | 2007 | 1268 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1400 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1565 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 74359 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
Laboratories | 1 | 2021 | 462 | 0.040 |
Why?
|
Social Class | 1 | 2006 | 2005 | 0.040 |
Why?
|
Brain | 1 | 2024 | 26951 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1982 | 0.040 |
Why?
|
Respiratory System | 1 | 2020 | 557 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1007 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1832 | 0.030 |
Why?
|
Health Promotion | 1 | 2007 | 2206 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
Specimen Handling | 1 | 2020 | 707 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1004 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
Cross Infection | 1 | 2024 | 1434 | 0.030 |
Why?
|
Haiti | 2 | 2007 | 549 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1456 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 658 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1296 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2022 | 1885 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4573 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2021 | 1273 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1174 | 0.030 |
Why?
|
Child | 1 | 2020 | 79806 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
Learning | 1 | 2021 | 1739 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5423 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8803 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3736 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6479 | 0.020 |
Why?
|
Primary Health Care | 1 | 2007 | 4647 | 0.020 |
Why?
|
Animals | 2 | 2020 | 167963 | 0.020 |
Why?
|
Smoking | 1 | 2006 | 9073 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4219 | 0.020 |
Why?
|
Prevalence | 1 | 2006 | 15687 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9335 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5397 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3562 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6771 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6828 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 40165 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4283 | 0.020 |
Why?
|
Elephantiasis | 1 | 2007 | 11 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5889 | 0.020 |
Why?
|
Dominican Republic | 1 | 2007 | 74 | 0.020 |
Why?
|
Philippines | 1 | 2007 | 91 | 0.020 |
Why?
|
Egypt | 1 | 2007 | 98 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2653 | 0.020 |
Why?
|
Burkina Faso | 1 | 2007 | 86 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54303 | 0.020 |
Why?
|
Ghana | 1 | 2007 | 312 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8594 | 0.020 |
Why?
|
Wuchereria bancrofti | 1 | 2005 | 20 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.020 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6465 | 0.010 |
Why?
|
Sentinel Surveillance | 1 | 2005 | 293 | 0.010 |
Why?
|
Government Programs | 1 | 2005 | 280 | 0.010 |
Why?
|
Tanzania | 1 | 2007 | 1383 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2007 | 1677 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36060 | 0.010 |
Why?
|
Ophthalmology | 1 | 2007 | 549 | 0.010 |
Why?
|
Health Services Research | 1 | 2007 | 1810 | 0.010 |
Why?
|
Research | 1 | 2007 | 1974 | 0.010 |
Why?
|
Health Education | 1 | 2005 | 1049 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29932 | 0.010 |
Why?
|
Health Surveys | 1 | 2007 | 4063 | 0.010 |
Why?
|
Patient Care Team | 1 | 2007 | 2511 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 87810 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2007 | 1939 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6498 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 10344 | 0.010 |
Why?
|
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(91)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_